Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes
Pathogens · 30.07.2026 · 15 (8) · 804
DOI: 10.3390/pathogens15080804 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathogens, online erschienen am 30.07.2026. Verfasst von Petar Vasilev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B virus. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by Medical University - Plovdiv through intramural research project No. 20/2026, entitled "Interventional epidemiological and molecula…, Medical University—Plovdiv.
Abstract (Originalsprache)
Acute hepatitis B virus (HBV) infection is rare during infancy, and severe symptomatic HBV-associated hepatitis is even less common. We describe two siblings who developed severe HBV-associated liver injury during infancy, two years apart, but experienced markedly divergent clinical outcomes. Clinical, laboratory, virological, microbiological, imaging, therapeutic, and follow-up data were retrospectively reviewed. Household members were subsequently tested for HBV and HDV. The first infant, a 5-month-old girl, presented with HBsAg positivity, negative serological markers for HAV, HCV, and HEV, and severe acute liver injury with a fulminant clinical course that resulted in death. Because anti-HBc IgM, HBV DNA, repeat HBsAg testing, and follow-up serology were unavailable, acute HBV infection could not be confirmed, and the episode was therefore classified as presumed HBV-associated fulminant hepatitis. The rapidly fatal clinical course precluded a comprehensive etiological evaluation, and the available medical records did not fully document the diagnostic work-up. The second patient, a 4-month-old boy, presented with serological and molecular evidence of acute HBV infection, including low-level HBV DNA, total anti-HDV positivity of uncertain clinical significance, and positive CMV IgM/IgG serology. He also had a urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Without HDV RNA and CMV DNA testing, active HDV infection and clinically significant CMV disease could not be definitively confirmed, while passive transfer of maternal anti-HDV antibodies could not be excluded. The patient required prolonged hospitalization, during which he received supportive, replacement, and antimicrobial therapy. He recovered, and long-term follow-up demonstrated HBsAg clearance with undetectable HBV DNA. Testing of household members revealed chronic HBV infection in the mother and maternal grandmother, both of whom had detectable HDV RNA, consistent with ongoing HBV/HDV circulation within the family. However, without viral sequence data from the infants, the source, route, timing, and direction of transmission could not be established. These cases illustrate the potential severity of HBV-associated hepatitis during infancy and its highly variable clinical outcomes. They also underscore the importance of antenatal HBV screening, timely immunoprophylaxis, and cautious interpretation of suspected viral coinfections when molecular confirmation is unavailable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.
- Clinic of Infectious Diseases, University Multipurpose Hospital for Active Treatment "Sveti Georgi", 4002 Plovdiv, Bulgaria.
- Center for Emergency Medical Care, 4002 Plovdiv, Bulgaria.
- Department of Infectious Diseases, Pulmed University Hospital, 4002 Plovdiv, Bulgaria.
- Section of Epidemiology, Department of Epidemiology and Disaster Medicine, Faculty of Public Health, Medical University, 4002 Plovdiv, Bulgaria.
- Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.
ORCID-Profile: Petar Vasilev, Petya Argirova, Velina Stoeva
Förderung
- This research was funded by Medical University - Plovdiv through intramural research project No. 20/2026, entitled "Interventional epidemiological and molecula…
- Medical University—Plovdiv
Zitieren
APA
Vasilev, P., Badarov, Z., Todev, A., Argirova, P., Stoeva, V., Chopova, B., Atanasova, M., Baltadzhiev, I., & Stoycheva-Vartigova, M. (2026). Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes. Pathogens, 15(8), 804. https://doi.org/10.3390/pathogens15080804
Vancouver
Vasilev P, Badarov Z, Todev A, Argirova P, Stoeva V, Chopova B, et al. Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes. Pathogens. 2026;15(8):804. doi:10.3390/pathogens15080804
BibTeX
@article{Vasilev2026,
author = {Vasilev, Petar and Badarov, Zhelyazko and Todev, Angel and Argirova, Petya and Stoeva, Velina and Chopova, Boriana and Atanasova, Maria and Baltadzhiev, Ivan and Stoycheva-Vartigova, Mariyana},
title = {Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {8},
pages = {804},
doi = {10.3390/pathogens15080804}
}
EUVIMED